Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT04039230
Title Study to Evaluate Sacituzumab Govitecan in Combination With Talazoparib in Patients With Metastatic Breast Cancer.
Recruitment Recruiting
Gender female
Phase Phase Ib/II
Variant Requirements No
Sponsors Massachusetts General Hospital

triple-receptor negative breast cancer


Sacituzumab govitecan-hziy + Talazoparib

Age Groups: adult | senior
Covered Countries USA

No variant requirements are available.